Related Experiment Video
Updated: Aug 16, 2026

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma
Uta B Hofmann1, Andreas A O Eggert, Katharina Blass
1Department of Dermatology, Julius Maximilians University, Josef-Schneider-Street 2, 97080 Würzburg, Germany. hofmann_u1@klinik.uni-wuerzburg.de
Abstract:
Matrix metalloproteinases (MMPs) are essential for tumor progression, invasion and metastases formation. Expression of these proteinases is not only restricted to the tumor cells themselves, but also is found in normal stromal cells. Moreover, immunohistochemistry suggests stromal cells as the major source. To scrutinize this hypothesis we established a slowly growing, syngeneic tumor model using the B16-melanoma cell line B78D14. In vitro analysis demonstrated that B78D14 cells secreted MMP-2, MT1-MMP, and to a lesser degree MMP-9; in addition they expressed both MT1-MMP and EMMPRIN on their surface. In subcutaneous (s.c.) tumors of these cells MMP-2 expression was predominantly present at the tumor-stroma border indicating stromal cells as primary source for this protease in vivo. Indeed, double staining experiments and in situ zymography confirmed that tumor adjacent stromal cells at the invasive front expressed MMP-2 and only at this site activated MMP-2 was detectable. Notably, in an experimental pulmonary metastases model neither tumor nor stromal cells expressed MMP-2, suggesting that the capacity of stromal cells is largely dependent on the surrounding microenvironment.
Insights
Stromal cells are the primary source of matrix metalloproteinase-2 (MMP-2) in B16-melanoma tumors, particularly at the invasive front. However, MMP-2 expression by stromal cells depends on the tumor microenvironment.
Area of Science:
- Oncology
- Cancer Biology
- Protease Function
Background:
- Matrix metalloproteinases (MMPs) play a critical role in tumor progression, invasion, and metastasis.
- MMP expression is observed in both tumor and stromal cells, with immunohistochemistry suggesting stromal cells as a major source.
- Understanding the cellular source of MMPs is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the cellular origin of MMP-2 in a syngeneic B16-melanoma tumor model.
- To determine the role of the tumor microenvironment in regulating stromal cell MMP expression.
- To analyze MMP secretion and expression profiles of B16-melanoma cells in vitro and in vivo.
Main Methods:
- Establishment of a slowly growing, syngeneic B16-melanoma (B78D14) tumor model.
- In vitro analysis of MMP secretion and cell surface protein expression by B78D14 cells.
- Subcutaneous tumor implantation and analysis using immunohistochemistry and in situ zymography.
- Experimental pulmonary metastasis model to assess MMP-2 expression in different microenvironments.
Main Results:
- B16-melanoma cells secreted MMP-2, MT1-MMP, and MMP-9 in vitro and expressed MT1-MMP and EMMPRIN on their surface.
- In subcutaneous tumors, MMP-2 expression was concentrated at the tumor-stroma border, indicating stromal cells as the primary in vivo source.
- Double staining and in situ zymography confirmed MMP-2 expression and activation in tumor-adjacent stromal cells at the invasive front.
- Neither tumor nor stromal cells expressed MMP-2 in an experimental pulmonary metastasis model.
Conclusions:
- Stromal cells are the predominant source of MMP-2 in B16-melanoma tumors, particularly at the invasive front.
- The expression and activation of MMP-2 by stromal cells are highly dependent on the tumor microenvironment.
- These findings highlight the importance of the tumor microenvironment in regulating protease activity during cancer progression.
Related Concept Videos
The Tumor Microenvironment
Mesenchymal Stem Cells
Role of Matrix Metalloproteases in Degradation of ECM
A...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
